Precigen Share Price

Precigen Share Price

NASDAQ: PGEN | Small Cap | Healthcare
$4.21
+$0.07 (1.69%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Precigen Stock Performance

Open
$4.16
Prev. Close
$4.14
Circuit Range
N/A
Day Range
$4.07 - $4.36
Year Range
$3.04 - $8.98
Volume
3,16,259
Average Traded
$4.22

Precigen Share Price Today

As of 21 November 2026, Precigen, Inc.'s share price is $4.21. The stock opened at $4.16, compared to its previous close of $4.14. During today's trading session, Precigen, Inc.'s share price traded between $4.07 and $4.36, with an average price of $4.21. Over the past 52 weeks, the stock has recorded a high of $8.98 and a low of $3.04. In terms of performance, Precigen, Inc.'s share price has declined by 3.00% over the last six months and is up 10.21% on a year-on-year basis.

Precigen Share Price Chart

Line chart of the Precigen price trend over the selected period. The price rose overall, ranging from 4.09 to 4.34, ending at 4.20.
$4.07$4.36
L
Show Current Price
H

Precigen Stock Fundamentals & Key Indicators

Market Cap
$1.32B
PE Ratio (TTM)
61.85
Dividend Yield
0.00%
EPS (TTM)
$0.07
Revenue (TTM)
$9.68B
Return On Equity (TTM)
29.12%
Profit Margin
-4438.43%
Debt to Equity
1.12
Quarterly Earnings Growth YoY
252.21%

Precigen Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$4.57$23.25$54.98$74.15
Net Profit-$23.50-$7.93$20.07$35.77
Net Profit Margin-514.22%-34.11%36.50%48.24%
Income ChangeN/A66.26%353.09%78.23%

Precigen Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$26.91$6.23$3.93$9.68
Net Profit$28.32-$95.90-$126.24-$429.64
Net Profit Margin105.24%-1539.33%-3212.21%-4438.43%
Income ChangeN/A-438.63%-31.64%-240.34%

Precigen Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets40.2742.8582.2997.82
Current Assets115.24102.4168.76118.16
Total Assets155.51145.27151.04215.98
Non Current Liabilities97.2957.029.5611.07
Current Liabilities37.3121.5222.9978.65
Total Liabilities134.5978.5432.5589.72
Shareholders' Equity20.9138.51118.5126.26

Precigen Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-87.83-68.17-66.93-65.05
Investing-1.54-20.71-3.09226.42
Financing90.05110.5829.59-155.29

About Precigen

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Precigen Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$5.32
$4.22
-39.19%
Oct 2026
$8.53
$6.94
-19.11%
Sep 2026
$6.87
$8.58
+19.50%
Aug 2026
$6.22
$7.18
+14.51%
Jul 2026
$5.67
$6.27
+10.00%
Jun 2026
$4.30
$5.70
+31.34%
May 2026
$4.14
$4.34
+4.33%
Apr 2026
$3.80
$4.16
+7.77%
Mar 2026
$3.69
$3.86
+1.71%
Feb 2026
$4.42
$3.79
-15.67%
Jan 2026
$4.18
$4.50
+7.91%
Dec 2025
$3.77
$4.17
+9.16%

Precigen Share Price FAQs